Novartis Enters Settlement Agreement for Remaining Members of Gender Bias Suit
Following a massive $250 million punitive damages verdict from a Manhattan jury, Swiss pharmaceutical company Novartis has agreed to settle the remaining claims in a recent gender bias suit. Pending final approval by the district judge, the settlement would be more than $152 million and would cover the remainder of the 5,600 claims filed in […]